Financial Ratios

SECUNDERABAD HEALTHCARE LTD.

NSE : NABSE : 524540ISIN CODE : INE930C01016Industry : Hospital & Healthcare ServicesHouse : Private
BSE0.920 (0 %)
PREV CLOSE ( ) 0.92
OPEN PRICE ( ) 0.92
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3001
TODAY'S LOW / HIGH ( )0.92 0.92
52 WK LOW / HIGH ( ) 0.920.92
NSE
This Company is not listed in NSE
Select year
ParticularsMar2017Mar2016Mar2015Mar2014Mar2013
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.020.010.010.010.00
   CEPS(Rs)0.020.050.060.030.06
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)18.7618.7718.7618.7518.74
   Tax Rate(%)1.54-32.01-67.8016.9134.39
Margin Ratios
   Core EBITDA Margin(%)7.3612.935.851.972.27
   EBIT Margin(%)-30.222.831.281.050.30
   Pre Tax Margin(%)-31.372.641.200.970.27
   PAT Margin (%)-30.893.492.010.810.18
   Cash Profit Margin (%)36.0214.367.553.573.24
Performance Ratios
   ROA(%)-0.090.060.060.030.01
   ROE(%)-0.100.070.080.040.02
   ROCE(%)-0.090.050.050.050.02
   Asset Turnover(x)0.000.020.030.040.07
   Sales/Fixed Asset(x)0.070.430.841.062.05
   Working Capital/Sales(x)0.090.651.231.733.44
Efficiency Ratios
   Fixed Capital/Sales(x)14.472.351.200.940.49
   Receivable days8298.232148.981168.631123.61783.50
   Inventory Days2140.03349.77162.96107.3150.06
   Payable days0.002396.941185.581163.47807.03
Valuation Parameters
   PER(x)0.00114.62269.592519.749013.51
   PCE(x)66.1127.8771.82572.61499.76
   Price/Book(x)0.080.080.211.021.54
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)33.049.098.0123.8819.34
   EV/Core EBITDA(x)90.0366.35117.43597.30549.69
   EV/EBIT(x)-109.34321.02623.942166.256193.56
   EV/CE(x)0.100.150.260.911.28
   M Cap / Sales23.824.005.4221.4216.96
Growth Ratio
   Net Sales Growth(%)-83.76-49.05-17.68-47.62-36.86
   Core EBITDA Growth(%)-56.492.3340.41-40.47-38.62
   EBIT Growth(%)-273.3512.36-4.1684.94-88.00
   PAT Growth(%)-243.72-11.6896.08135.27-94.56
   EPS Growth(%)-243.72-11.5894.74136.62-94.56
Financial Stability Ratios
   Total Debt/Equity(x)0.030.100.100.120.22
   Current Ratio(x)5.651.271.321.221.18
   Quick Ratio(x)3.181.101.131.101.09
   Interest Cover(x)-26.1315.1615.3512.9512.28
   Total Debt/Mcap(x)0.391.270.480.110.14

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.